SCHEMBL27345173

SCHEMBL27345173

COC(=O)c1ccc(N2CCC(CO)C2)cc1C=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
MAPT P10636 9/20 0.39
ALDH1A1 P00352 9/20 0.39
MCL1 Q07820 3/20 0.39
ALOX15 P16050 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
USP2 O75604 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
GFER P55789 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 3/20 0.39
POLB P06746 1/20 0.39
USP30 Q70CQ3 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27345174 1.00 KDM4E (0.43) KDM4EMEN1KMT2AMAPTALDH1A1
SCHEMBL24207467 1.00 KDM4E (0.43) KDM4EMEN1KMT2AMAPTALDH1A1
SCHEMBL21876917 0.93 BRD4 (0.42) KDM4EMEN1KMT2AMAPTALDH1A1
SCHEMBL31312877 0.91 KMT2A (0.39) KDM4EMEN1KMT2AALDH1A1CYP1A2
SCHEMBL24421386 0.91 KMT2A (0.39) KDM4EMEN1KMT2AALDH1A1CYP1A2
SCHEMBL25370050 0.86 PTPN1 (0.41) USP30NOTUMBRD4
SCHEMBL25370055 0.86 PTPN1 (0.41) USP30NOTUMBRD4
SCHEMBL26969667 0.86 PTPN1 (0.41) USP30NOTUMBRD4
SCHEMBL29614639 0.84 BRD4 (0.44) KDM4EMEN1KMT2AMAPTALDH1A1
SCHEMBL24421376 0.84 BRD4 (0.44) KDM4EMEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023245150-A1 KAT6 TARGETING COMPOUNDS WITH UBIQUITIN LIGASE BINDING MOIETY PRELUDE THERAPEUTICS INCORPORATED (US) 2023-12-21 WO disclosed